Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis

Hélène Haguet, Jonathan Douxfils, François Mullier, Christian Chatelain, Carlos Graux, Jean Michel Dogné

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science